We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cbaysystems | LSE:CBAY | London | Ordinary Share | VGG1986L1022 | ORD USD0.10 (REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 139.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/7/2009 23:17 | MEDQ up to $7.20+ now almost double the price when i bought in a few months ago.... yet CBAY sits at almost exactly the same price.... | stegrego | |
17/7/2009 11:41 | Some decent buys here...quite a shock..:o) wonder if this will trigger a move up now. | nurdin | |
08/7/2009 08:46 | MedQ up 10% last night Steg, now trading at $6.13 mid. Market cap now at $231m which makes Cbays stake worth $162m Q1 results hard to decipher but adjusted net earnings (pre exceptionals)appear to be at $6m.Annualised,this suggests full year earnings of $24m or eps of 9.55p at the current exchange rate. Current year PE of around 4.5...if I have done my sums correctly! CBay look grosssly undervalued on any measure imo. | nurdin | |
02/7/2009 07:49 | Someone bought 25000 yesterday after Q1 results. Still seems plenty of litigation on the table at MedQ. MedQ share price holding up nicely in the US though. | stegrego | |
30/6/2009 12:44 | Yep, i too thought they has said all the legal stuff was done with... Re the buy - well, it wasnt me - i thought it might be you! | stegrego | |
30/6/2009 09:49 | Yes looks like the reason behind the rise although I am somewhat surprised as they have previously stated that all outstanding litigations had been settled.Never mind,the share price recorded a net increase of 16% over the last couple of sessions. See we have a buyer...nearly fell off my chair when I saw the trade :o) | nurdin | |
29/6/2009 22:55 | I assume this is why the share has jumped.... MedQuist Inc. (the "Company") entered into a Settlement and License Agreement (the "Settlement Agreement") by and between Anthurium Solutions, Inc. ("Anthurium") and the Company on June 19, 2009 (the "Effective Date"). As previously disclosed by the Company, on November 6, 2007, Anthurium filed an action (the "Lawsuit") entitled Anthurium Solutions, Inc. v. MedQuist Inc., et al., Civil Action No. 2-07CV-484, in the United States District Court for the Eastern District of Texas, seeking damages for the alleged infringement by the Company of United States Patent No. 7,031,998 (the "'998 Patent") through the Company's DocQment™ Enterprise Platform ("DEP"). The Company denies the allegations set forth in the complaint filed by Anthurium in the Lawsuit and asserted affirmative defenses alleging that the '998 patent is invalid, not infringed and unenforceable. Pursuant to the Settlement Agreement, Anthurium will receive $5,750,000 from the Company and $100,000 from CBay Systems Holdings, Ltd. ("CBay Holdings") in return for a non-exclusive, fully paid-up, royalty-free, and worldwide license of the Anthurium Patents to the Company, the Company's subsidiaries, CBay Holdings and the medical transcription companies controlled by CBay Holdings (collectively referred to as the "MedQuist Affiliates"). The settlement for the Company and its subsidiaries was negotiated separately and independently from the settlement for CBay Holdings and the other medical transcription companies controlled by CBay Holdings. For convenience, both settlements were addressed in the single Settlement Agreement. The Anthurium Patents are defined as (i) the '998 Patent, (ii) any other patent owned or controlled by Anthurium as of the Effective Date, (iii) any patent which issues after the Effective Date from an application owned or controlled by Anthurium prior to the Effective Date and (iv) any and all other patents and applications from which any or all of the foregoing patents claim priority or are derived through continued prosecution, division, continuation, continuation-in-part The Settlement Agreement further provides that the MedQuist Affiliates and Anthurium release one another from any and all liability or obligations, past or present, arising under, out of, or in any manner connected with the alleged infringement of the Anthurium Patents. In addition, pursuant to the Settlement Agreement, Anthurium is precluded from asserting against the MedQuist Affiliates any claim arising from or related to any infringement, misappropriation or violation of any intellectual property right (other than a trademark right), for a period of three (3) years following the Effective Date. The Company has not admitted nor will it admit to liability or any wrongdoing in connection with the settlement. The Company has no material relationship with Anthurium other than the Lawsuit and the Settlement Agreement. CBay Holdings is the parent of the Company's majority shareholder, CBay, Inc., which owns approximately 70% of the Company's outstanding common stock. The Company will file a copy of the Settlement Agreement as an exhibit to its Quarterly Report on Form 10-Q for the quarter ended June 30, 2009. | stegrego | |
26/6/2009 22:16 | lol..ok.done :o) | nurdin | |
26/6/2009 19:13 | Nurdin, what i think we should do is keep this quiet, until results next quarter, then if they are good - buy a shed load and THEN tell people about it ;) | stegrego | |
26/6/2009 16:19 | MedQ up 4.6% and now capitalised at $204m. This carp doesnt seem to want to budge.. I give up :o( | nurdin | |
16/6/2009 07:46 | Yup up 6.6% yesterday.MedQ market cap now straddling $188m..that makes CBay stake worth $130m!! Very frustrating.. | nurdin | |
15/6/2009 21:44 | MedQ making the $5 mark today - highest since last September.... | stegrego | |
09/6/2009 22:31 | Well, this is exciting :) MedQ seems pretty steady / slightly rising in US. | stegrego | |
27/5/2009 07:30 | Yes I am struggling to understand the results too but the headline numbers were as expected, having already been flagged by the Medquist results for the same period. Will be going through the numbers with a fine toothcomb today. Perhaps what matters now is how they perform going forward...the Q1 results from MedQ atleast give some positive pointers. | nurdin | |
26/5/2009 19:29 | Results out but not easy to understand. Looks like costs are droppiing Dont think anyone will even notice I guess next quarter results from USA may attract attention. Still struggling with this lots accounts | stegrego | |
22/5/2009 16:33 | watching from the sidelines, but it seems to get all the more compelling, will see over the weekend, cheers for all the input, I may update the header if I get a chance, have a good weekend all, i'm off to the canaries on the Independance of the seas on wednesday. | cambium | |
22/5/2009 16:29 | you still in these cambium? | nurdin | |
22/5/2009 12:55 | Hope the results are good and more importantly that the outlook is clear and they paint a good picture re the current market cap vs assets. Im away all next week, so will read results but cant sell anyway as i dont think etrade does a phone service. | stegrego | |
22/5/2009 12:51 | Agreed...this one is quite interesting too with regard to the market size in the USA. Mirrus is a wholly owned subsiduary of Cbay | nurdin | |
22/5/2009 12:45 | Worth copying the text on that i think Nurdin. CBay Systems opens centre in Coimbatore Our Bureau Coimbatore, April 30 Medical transcription services company CBay Systems is in the process of expanding its operations in India (with the opening of a centre in Coimbatore) and strengthening its position in Sri Lanka. Addressing news persons after inaugurating its office at Rathinam Technopark at Eachanari near here, its Director and Chief Operating Officer (India Operations), Mr Dinesh Kumar, said the facility, spread over 18,000 sq ft (covering two storeys) would have a seating capacity of 450 people. Increase headcounts In the first phase, the company is planning to increase its headcount (in Coimbatore) to around 700 by December 2009 and thereafter expand its operations and double the headcount to 1500 over the next 12 months. It has initiated discussions with select institutions in the city for hiring candidates off campus. 'To induct fresh talent, we will extend our training programme in these institutions and get a ready talent base,' he said 'The new centre is completely owned by CBay and located in the STPI region. The investment is Rs 11 crore,' Mr Kumar said and added that the company would begin campus recruitment from 2010. Besides this facility in Coimbatore, CBay operates three franchisees here and the total seats estimated at 600. The company has 42 India-based delivery centres and one each in Oman, Bhutan, Sri Lanka and Barbados. It has an overall capacity of 3,000 seats. 'We have added 1,800 new seats in 2009, including the satellite units at Bangalore and Hyderabad, on a total estimated outlay of Rs 45 crore,' Mr Kumar said Asked the global economic turmoil had any impact on the medical transcription industry and his company in particular, he said 'we are recession-free. | stegrego | |
22/5/2009 08:42 | He who dares eh steg? :o) Cbays stake in MedQ now worth £74m | nurdin |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions